메뉴 건너뛰기




Volumn 25, Issue 7, 2007, Pages 813-821

Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ESOMEPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RANITIDINE;

EID: 33947195984     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03210.x     Document Type: Article
Times cited : (21)

References (29)
  • 1
    • 0032476644 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: Definitions and epidemiology
    • McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology. Am J Med 1998; 105: 3S-9S.
    • (1998) Am J Med , vol.105
    • McCarthy, D.1
  • 2
    • 0033965104 scopus 로고    scopus 로고
    • Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices
    • Cullen DJ, Seager JM, Holmes S, et al. Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices. Aliment Pharmacol Ther 2000; 14: 177-85.
    • (2000) Aliment Pharmacol Ther , vol.14 , pp. 177-185
    • Cullen, D.J.1    Seager, J.M.2    Holmes, S.3
  • 3
    • 0033978372 scopus 로고    scopus 로고
    • Gastroesophageal reflux disease: Prevalence, clinical, endoscopic and histopathological findings in 1128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms
    • Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000; 61: 6-13.
    • (2000) Digestion , vol.61 , pp. 6-13
    • Voutilainen, M.1    Sipponen, P.2    Mecklin, J.P.3    Juhola, M.4    Farkkila, M.5
  • 4
    • 0033925632 scopus 로고    scopus 로고
    • The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: A prospective 13 year study of 2131 patients
    • Wolfe F, Hawley DJ. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients. J Rheumatol 2000; 27: 1668-73.
    • (2000) J Rheumatol , vol.27 , pp. 1668-1673
    • Wolfe, F.1    Hawley, D.J.2
  • 5
    • 0034857583 scopus 로고    scopus 로고
    • Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population
    • Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm Res 2001; 18: 1367-72.
    • (2001) Pharm Res , vol.18 , pp. 1367-1372
    • Kotzan, J.1    Wade, W.2    Yu, H.H.3
  • 6
    • 0036936615 scopus 로고    scopus 로고
    • The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
    • Laine L. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum 2002; 32 (3 Suppl. 1): 25-32.
    • (2002) Semin Arthritis Rheum , vol.32 , Issue.3 SUPPL. 1 , pp. 25-32
    • Laine, L.1
  • 7
    • 0033601079 scopus 로고    scopus 로고
    • Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
    • Langman MJ, Jensen DM, Watson DJ, et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999; 282: 1929-33.
    • (1999) JAMA , vol.282 , pp. 1929-1933
    • Langman, M.J.1    Jensen, D.M.2    Watson, D.J.3
  • 8
    • 0034644396 scopus 로고    scopus 로고
    • Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study
    • Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA 2000; 282: 1247-55.
    • (2000) JAMA , vol.282 , pp. 1247-1255
    • Silverstein, F.E.1    Faich, G.2    Goldstein, J.L.3
  • 9
    • 0142028961 scopus 로고    scopus 로고
    • Gastrointestinal tolerability and effectiveness of rofecoxib vs. naproxen in the treatment of osteoarthritis: A randomized, controlled trial
    • Lisse JE, Perlman M, Johannson G, et al. Gastrointestinal tolerability and effectiveness of rofecoxib vs. naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Ann Inter Med 2003; 139: 539-46.
    • (2003) Ann Inter Med , vol.139 , pp. 539-546
    • Lisse, J.E.1    Perlman, M.2    Johannson, G.3
  • 10
    • 20444467682 scopus 로고    scopus 로고
    • Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: An update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool
    • Veldhuyzen van Zanten SJO, Bradette M, Chiba N, et al. Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol 2005; 19: 285-303.
    • (2005) Can J Gastroenterol , vol.19 , pp. 285-303
    • Veldhuyzen van Zanten, S.J.O.1    Bradette, M.2    Chiba, N.3
  • 11
    • 0032066149 scopus 로고    scopus 로고
    • NSAID induced gastrointestinal complications: The ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System
    • Singh G, Rosen Ramey D. NSAID induced gastrointestinal complications: the ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl 1998; 25 (Suppl. 51): 8-16.
    • (1998) J Rheumatol Suppl , vol.25 , Issue.SUPPL. 51 , pp. 8-16
    • Singh, G.1    Rosen Ramey, D.2
  • 12
    • 0029982324 scopus 로고    scopus 로고
    • Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH
    • Elliot SL, Ferris RJ, Giraud AS, et al. Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH. Clin Exp Pharmacol Physiol 1996; 23: 432-4.
    • (1996) Clin Exp Pharmacol Physiol , vol.23 , pp. 432-434
    • Elliot, S.L.1    Ferris, R.J.2    Giraud, A.S.3
  • 13
    • 0034763257 scopus 로고    scopus 로고
    • Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs
    • McCarthy DM. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. Best Pract Clin Gastroenterol 2001; 15: 755-73.
    • (2001) Best Pract Clin Gastroenterol , vol.15 , pp. 755-773
    • McCarthy, D.M.1
  • 14
    • 0030016432 scopus 로고    scopus 로고
    • Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal antiinflammatory drug therapy. A Nordic multicentre study
    • Ekstrom P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal antiinflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 1996; 31: 753-8.
    • (1996) Scand J Gastroenterol , vol.31 , pp. 753-758
    • Ekstrom, P.1    Carling, L.2    Wetterhus, S.3
  • 15
    • 0035658894 scopus 로고    scopus 로고
    • Quality of life in chronic NSAID users: A comparison of the effect of omeprazole and misoprostol
    • Yeomans N, Wilson I, Langstrom G, et al. Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol. Scand J Rheumatol 2001; 30: 328-34.
    • (2001) Scand J Rheumatol , vol.30 , pp. 328-334
    • Yeomans, N.1    Wilson, I.2    Langstrom, G.3
  • 16
    • 19144370104 scopus 로고    scopus 로고
    • Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors
    • Hawkey C, Talley NJ, Yeomans ND, et al. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol 2005; 100: 1028-36.
    • (2005) Am J Gastroenterol , vol.100 , pp. 1028-1036
    • Hawkey, C.1    Talley, N.J.2    Yeomans, N.D.3
  • 17
    • 33645449670 scopus 로고    scopus 로고
    • Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors
    • Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006; 101: 701-10.
    • (2006) Am J Gastroenterol , vol.101 , pp. 701-710
    • Scheiman, J.M.1    Yeomans, N.D.2    Talley, N.J.3
  • 18
    • 33644819475 scopus 로고    scopus 로고
    • Healing of gastric ulcers with esomeprazole vs. ranitidine in patients who continued to receive NSAID therapy: A randomized trial
    • Goldstein JL, Johansen JF, Suchower LJ, Brown KA. Healing of gastric ulcers with esomeprazole vs. ranitidine in patients who continued to receive NSAID therapy: a randomized trial. Am J Gastroenterol 2005; 100: 2650-7.
    • (2005) Am J Gastroenterol , vol.100 , pp. 2650-2657
    • Goldstein, J.L.1    Johansen, J.F.2    Suchower, L.J.3    Brown, K.A.4
  • 19
    • 0032216688 scopus 로고    scopus 로고
    • Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non-ulcer dyspepsia
    • Junghard O, Lauritsen K, Talley NJ, et al. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non-ulcer dyspepsia. Eur J Surg Suppl 1998; 583: 106-11.
    • (1998) Eur J Surg Suppl , vol.583 , pp. 106-111
    • Junghard, O.1    Lauritsen, K.2    Talley, N.J.3
  • 20
    • 33745653498 scopus 로고    scopus 로고
    • Validation of a 4-graded scale for severity of heartburn in symptomatic GERD patients [abstract]
    • Junghard O, Wiklund I. Validation of a 4-graded scale for severity of heartburn in symptomatic GERD patients [abstract]. Gut 2004; 53 (Suppl. VI): A103.
    • (2004) Gut , vol.53 , Issue.SUPPL. VI
    • Junghard, O.1    Wiklund, I.2
  • 21
    • 0028508838 scopus 로고
    • Nonsteroidal antiinflammatory drugs and the gastrointestinal tract
    • Hirschowitz BI. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. Gastroenterologist 1994; 2: 207-23.
    • (1994) Gastroenterologist , vol.2 , pp. 207-223
    • Hirschowitz, B.I.1
  • 22
    • 0032923370 scopus 로고    scopus 로고
    • The epidemiology of non-steroidal anti-inflammatory drugs
    • Tenenbaum J. The epidemiology of non-steroidal anti-inflammatory drugs. Can J Gastroenterol 1999; 13: 119-22.
    • (1999) Can J Gastroenterol , vol.13 , pp. 119-122
    • Tenenbaum, J.1
  • 23
    • 1542377480 scopus 로고    scopus 로고
    • Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease
    • Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004; 126: 660-4.
    • (2004) Gastroenterology , vol.126 , pp. 660-664
    • Johnson, D.A.1    Fennerty, M.B.2
  • 25
    • 0033636764 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: Mechanisms and prevention
    • Rich M, Scheiman JM. Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: mechanisms and prevention. Semin Arthritis Rheum 2000; 30: 167-79.
    • (2000) Semin Arthritis Rheum , vol.30 , pp. 167-179
    • Rich, M.1    Scheiman, J.M.2
  • 26
    • 0021256898 scopus 로고
    • Effect of indomethacin on basal and histamine-stimulated human gastric acid secretion
    • Levine RA, Schwartzel EH. Effect of indomethacin on basal and histamine-stimulated human gastric acid secretion. Gut 1984; 25: 718-22.
    • (1984) Gut , vol.25 , pp. 718-722
    • Levine, R.A.1    Schwartzel, E.H.2
  • 27
    • 0031959523 scopus 로고    scopus 로고
    • Effect of one-month treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients
    • Savarino V, Mela GS, Zentilin P, et al. Effect of one-month treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients. Dig Dis Sci 1998; 43: 459-63.
    • (1998) Dig Dis Sci , vol.43 , pp. 459-463
    • Savarino, V.1    Mela, G.S.2    Zentilin, P.3
  • 28
    • 0033082191 scopus 로고    scopus 로고
    • Gastric emptying of solids in long-term NSAID users: Correlation with endoscopic findings and Helicobacter pylori status
    • Kulkarni SG, Parikh SS, Shankhpal PD, et al. Gastric emptying of solids in long-term NSAID users: correlation with endoscopic findings and Helicobacter pylori status. Am J Gastroenterol 1999; 94: 382-6.
    • (1999) Am J Gastroenterol , vol.94 , pp. 382-386
    • Kulkarni, S.G.1    Parikh, S.S.2    Shankhpal, P.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.